Fulcrum Therapeutics, Inc. (FULC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Fulcrum Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.57x | -29.96x | -4.25x | -2.98x | -7.74x | -4.19x |
| P/B Ratio | 2.05x | 1.20x | 1.76x | 1.65x | 2.96x | 3.12x |
| P/S Ratio | 0.00x | 3.64x | 147.54x | 51.65x | 32.64x | 33.65x |
| Profitability | ||||||
| Gross Margin | 0.0% | 20.8% | 100.0% | -1110.7% | -263.7% | -569.2% |
| Operating Margin | 0.0% | -27.4% | -3945.2% | -1774.9% | -423.0% | -811.6% |
| Net Margin | 0.0% | -12.2% | -3470.1% | -1732.4% | -421.9% | -802.7% |
| EBITDA Margin | 0.0% | -22.8% | -3867.8% | -1730.1% | -409.8% | -784.7% |
| Liquidity | ||||||
| Current Ratio | 27.40x | 22.63x | 17.71x | 12.41x | 11.77x | 4.23x |
| Quick Ratio | 27.40x | 22.63x | 17.71x | 12.41x | 11.80x | 4.33x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.04x | 0.05x | 0.07x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..